Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurebayashi, S.
Right arrow Articles by Kishimoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurebayashi, S.
Right arrow Articles by Kishimoto, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 12 2115-2118, Copyright © 1997 by American Diabetes Association


ARTICLES

Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes

S Kurebayashi, T Hirose, Y Miyashita, S Kasayama and T Kishimoto
Department of Medicine III, Osaka University Medical School, Suita City, Japan.

Thiazolidinediones (TZDs) are known to have potent increases of insulin sensitivity. Because peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a receptor for TZDs, is mainly expressed in adipocytes, we tried to search the TZD-targeted genes in mouse 3T3-L1 adipocytes. By the mRNA differential display method, one band repressed by troglitazone was obtained, which corresponded to the partial sequences of the stearoyl-CoA desaturase 1 (SCD1) gene. Troglitazone dramatically decreased SCD1 mRNA levels in 3T3-L1 adipocytes in a dose-dependent manner. Pioglitazone also repressed the SCD1 mRNA expression, whereas WY-14,643 had no apparent effect. Both troglitazone and pioglitazone raised the composition (weight percentage) of myristic acid (C14:0), palmitic acid (C16:0), and stearic acid (C18:0), but lowered the composition of the delta9-cis desaturated fatty acids such as myristoleic acid (C14:1, delta9), palmitoleic acid (C16:1, delta9), oleic acid (C18:1, delta9), and linoleic acid (C18:2, delta9,12). These results indicate that TZDs repress SCD1 activity in 3T3-L1 adipocytes via downregulating SCD1 enzyme gene expression.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
U. Riserus, G. D. Tan, B. A. Fielding, M. J. Neville, J. Currie, D. B. Savage, V. K. Chatterjee, K. N. Frayn, S. O'Rahilly, and F. Karpe
Rosiglitazone Increases Indexes of Stearoyl-CoA Desaturase Activity in Humans: Link to Insulin Sensitization and the Role of Dominant-Negative Mutation in Peroxisome Proliferator-Activated Receptor-{gamma}
Diabetes, May 1, 2005; 54(5): 1379 - 1384.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Wang, B. Kurdi-Haidar, and J. F. Oram
LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1
J. Lipid Res., May 1, 2004; 45(5): 972 - 980.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Castro-Chavez, V. K. Yechoor, P. K. Saha, J. Martinez-Botas, E. C. Wooten, S. Sharma, P. O'Connell, H. Taegtmeyer, and L. Chan
Coordinated Upregulation of Oxidative Pathways and Downregulation of Lipid Biosynthesis Underlie Obesity Resistance in Perilipin Knockout Mice: A Microarray Gene Expression Profile
Diabetes, November 1, 2003; 52(11): 2666 - 2674.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. H.S. Wilson, S. E. Eckenrode, Q.-Z. Li, Q.-G. Ruan, P. Yang, J.-D. Shi, A. Davoodi-Semiromi, R. A. McIndoe, B. P. Croker, and J.-X. She
Microarray Analysis of Gene Expression in the Kidneys of New- and Post-Onset Diabetic NOD Mice
Diabetes, August 1, 2003; 52(8): 2151 - 2159.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. D. Aleo, G. R. Lundeen, D. K. Blackwell, W. M. Smith, G. L. Coleman, S. W. Stadnicki, and W. M. Kluwe
Mechanism and Implications of Brown Adipose Tissue Proliferation in Rats and Monkeys Treated with the Thiazolidinedione Darglitazone, a Potent Peroxisome Proliferator-Activated Receptor-{gamma} Agonist
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1173 - 1182.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. G. Wahl, C. Kausch, F. Machicao, K. Rett, M. Stumvoll, and H.-U. Haring
Troglitazone Downregulates {Delta}-6 Desaturase Gene Expression in Human Skeletal Muscle Cell Cultures
Diabetes, April 1, 2002; 51(4): 1060 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Samuel, C. N. Nagineni, R. K. Kutty, W. T. Parks, J. S. Gordon, S. M. Prouty, J. J. Hooks, and B. Wiggert
Transforming Growth Factor-beta Regulates Stearoyl Coenzyme A Desaturase Expression through a Smad Signaling Pathway
J. Biol. Chem., January 4, 2002; 277(1): 59 - 66.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
Y.-C. Kim, F. E. Gomez, B. G. Fox, and J. M. Ntambi
Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes
J. Lipid Res., August 1, 2000; 41(8): 1310 - 1316.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
V. Giguère
Orphan Nuclear Receptors: From Gene to Function
Endocr. Rev., October 1, 1999; 20(5): 689 - 725.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. Samuel, R. K. Kutty, S. Nagineni, J. S. Gordon, S. M. Prouty, R. A. S. Chandraratna, and B. Wiggert
Regulation of Stearoyl Coenzyme A Desaturase Expression in Human Retinal Pigment Epithelial Cells by Retinoic Acid
J. Biol. Chem., July 27, 2001; 276(31): 28744 - 28750.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.